Literature DB >> 5459658

An electron microscopic and functional study of very low density lipoproteins in intestinal lymph.

R K Ockner, A L Jones.   

Abstract

Previous studies with fasting rats showed that the intestine produces endogenous very low density lipoproteins (VLDL) which resemble those in the plasma. Intestinal VLDL also were found to be important in lipid transport during absorption of saturated but not of unsaturated fat. These findings depended upon separations of a chylomicron-rich fraction (S(f) > 400) from VLDL (S(f) 20-400) by preparative ultracentrifugation methods based on particle flotation rates. The present studies correlate this method with electron microscopic measurement of lipoprotein particle size. Almost all intestinal lymph lipoprotein particles from fasting rats were less than 750 A in diameter, and could not be distinguished morphologically from plasma VLDL. Cholestyramine administration or bile diversion led to decreased lymph lipid output, correlating with marked reduction in VLDL. This supports the concept that lymph VLDL contain endogenous lipid which is reabsorbed from the intestinal lumen. During exogenous fatty acid absorption, lymph lipoprotein particle sizes were significantly smaller after administration of palmitate than after administration of linoleate, a finding consistent with ultracentrifugal evidence of the importance of VLDL in lipid transport during palmitate absorption. These studies fully confirm and extend earlier observations. Together, they show that the intestine is a source of endogenous VLDL in the fasting animal. In addition, significant quantities of exogenous lipid are transported in VLDL during palmitate absorption, whereas with linoleate absorption nearly all lipid is in chylomicrons. These findings indicate that the small intestine plays a role in lipoprotein metabolism which extends beyond the absorption of dietary fat.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5459658

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Transport of diacylalkylglycerols in chylomicrons and very low density lipoproteins of rat intestinal lymph following intragastric administration of 1,3-dioctadecenoyl-2-hexadecylglycerol.

Authors:  R E Pitas; M M Hagerty; R G Jensen
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

2.  The effect of various dietary factors on the size distribution of lymph fat particles in rat.

Authors:  M Boquillon; R Paris; J Clement
Journal:  Lipids       Date:  1977-06       Impact factor: 1.880

3.  Composition, particle size and role in dietary fat transport of two different lipoproteins of the intestinal lymph.

Authors:  M Boquillon; R Paris; J Clement
Journal:  Lipids       Date:  1972-06       Impact factor: 1.880

4.  Lipoprotein particles from the Golgi apparatus of guinea-pig liver.

Authors:  M J Chapman; G L Mills; C E Taylaur
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

5.  Synthesis and transport of lipoprotein particles by intestinal absorptive cells in man.

Authors:  G N Tytgat; C E Rubin; D R Saunders
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

6.  Effect of acute ethanol ingestion on fat absorption.

Authors:  M Boquillon
Journal:  Lipids       Date:  1976-12       Impact factor: 1.880

7.  Intestinal metabolism of plasma free fatty acids. Intracellular compartmentation and mechanisms of control.

Authors:  A Gangl; R K Ockner
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

8.  The intestine as a source of apolipoprotein A1.

Authors:  R M Glickman; P H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

9.  Effect of biliary diversion on rat mesenteric lymph apolipoprotein-I and high density lipoprotein.

Authors:  H R Bearnot; R M Glickman; L Weinberg; P H Green; A R Tall
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

10.  The different effects on the serum lipids and fecal steroids of high carbohydrate diets given orally or intravenously.

Authors:  L DenBesten; R H Reyna; W E Connor; L D Stegink
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.